Baxan
Baxan Brand names, Baxan Analogs
Baxan Brand Names Mixture
- None
Baxan Chemical_Formula
C16H17N3O5S
Baxan RX_link
http://www.rxlist.com/cgi/generic/cefadrox.htm
Baxan fda sheet
Baxan msds (material safety sheet)
Baxan Synthesis Reference
L. B. Crast, Jr., U.S. Pat. 3,489,752 (1969)
Baxan Molecular Weight
363.389 g/mol
Baxan Melting Point
197oC
Baxan H2O Solubility
1110 mg/L
Baxan State
Solid
Baxan LogP
-0.355
Baxan Dosage Forms
Capsule; Tablet; Oral liquid
Baxan Indication
For the treatment of the following infections (skin, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staphylococci and Streptococcus pyogenes
Baxan Pharmacology
Cefadroxil, a first-generation cephalosporin antibiotic, is used to treat urinary tract infections, skin and skin structure infections, pharyngitis, and tonsillitis.
Baxan Absorption
Cefadroxil is well absorbed on oral administration; food does not interfere with its absorption.
Baxan side effects and Toxicity
Nausea, vomiting, diarrhoea, allergic rashes may occur
Baxan Patient Information
Patients should be counseled that intibacterial drugs including DURICEF should only be used to treat bacterial infections. They do not treat viral infections (eg. the common cold). When DURICEF is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelyhood that bacteria will develop resistance and will not be treatable by DURICEF or other antibacterial drugs in the future.
Baxan Organisms Affected
Enteric bacteria and other eubacteria
